Optimizing Hydroxyurea Dosage With Pharmakokinetic in Patients Suffering of Moderate to Severe Sickle Cell Anemia

Clinical trial NCT06761560 · RECRUITING

Trial details

NCT number: NCT06761560
Sponsor: Yves Pastore
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Sickle Cell Disease (SCD)

Start date: 2026-02-03
Primary completion: 2028-11-25
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.